Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Impact of Clinical and Pathologic Features on Tumor-Infiltrating Lymphocyte Expansion from Surgically Excised Melanoma Metastases for Adoptive T-cell Therapy
Richard W. Joseph, Vijay R. Peddareddigari, Ping Liu, et al.
Clinical Cancer Research (2011) Vol. 17, Iss. 14, pp. 4882-4891
Open Access | Times Cited: 50

Showing 26-50 of 50 citing articles:

Recent Advances in the Biology, Therapy and Management of Melanoma
Lester M. Davids, Pu Wang, Peipei Guan, et al.
InTech eBooks (2013)
Open Access | Times Cited: 33
Influence of ipilimumab on expanded tumour derived T cells from patients with metastatic melanoma
Jon Bjoern, Rikke Lyngaa, Rikke Andersen, et al.
Oncotarget (2017) Vol. 8, Iss. 16, pp. 27062-27074
Open Access | Times Cited: 29
How to Make Immunotherapy an Effective Therapeutic Choice for Uveal Melanoma
Mariarosaria Marseglia, Adriana Amaro, Nicola Solari, et al.
Cancers (2021) Vol. 13, Iss. 9, pp. 2043-2043
Open Access | Times Cited: 23
Advances in the management of melanoma: targeted therapy, immunotherapy and future directions
Emma Dean, Paul Lorigan
Expert Review of Anticancer Therapy (2012) Vol. 12, Iss. 11, pp. 1437-1448
Closed Access | Times Cited: 28
Tumor-Infiltrating Lymphocyte Therapy for Melanoma: Rationale and Issues for Further Clinical Development
Geok Choo Sim, Jessica Chacon, Cara Haymaker, et al.
BioDrugs (2014) Vol. 28, Iss. 5, pp. 421-437
Closed Access | Times Cited: 26
Impact of age-, cancer-, and treatment-driven inflammation on T cell function and immunotherapy
Kylie M. Quinn, Apriliana E. R. Kartikasari, Rachel E. Cooke, et al.
Journal of Leukocyte Biology (2020) Vol. 108, Iss. 3, pp. 953-965
Open Access | Times Cited: 21
Sex dimorphism in the tumor microenvironment – From bench to bedside and back
Fei He, Andrea Rodgers Furones, Nils Landegren, et al.
Seminars in Cancer Biology (2022) Vol. 86, pp. 166-179
Open Access | Times Cited: 13
Predictors of Tumor-Infiltrating Lymphocyte Efficacy in Melanoma
Dragoslav Zikich, Jacob Schachter, Michal J. Besser
Immunotherapy (2015) Vol. 8, Iss. 1, pp. 35-43
Closed Access | Times Cited: 23
Tumor-Infiltrating Lymphocytes
Michal J. Besser, Ronnie Shapira‐Frommer, Jacob Schachter
The Cancer Journal (2015) Vol. 21, Iss. 6, pp. 465-469
Closed Access | Times Cited: 21
At the Bedside: Adoptive cell therapy for melanoma—clinical development
Jeffrey S. Weber
Journal of Leukocyte Biology (2014) Vol. 95, Iss. 6, pp. 875-882
Closed Access | Times Cited: 19
Adjuvant treatment for triple-negative breast cancer: a retrospective study of immunotherapy with autologous cytokine-induced killer cells in 294 patients
Yuhan Zhang, Shuaibing Wang, Yang Beibei, et al.
Cancer Biology and Medicine (2019) Vol. 16, Iss. 2, pp. 350-350
Open Access | Times Cited: 17
Selective effect of cytokine-induced killer cells on survival of patients with early-stage melanoma
Hong Li, Lan Huang, Linbo Liu, et al.
Cancer Immunology Immunotherapy (2016) Vol. 66, Iss. 3, pp. 299-308
Open Access | Times Cited: 15
Strategies to sensitize cancer cells to immunotherapy
Andrew George, İlyas Şahin, Benedito A. Carneiro, et al.
Human Vaccines & Immunotherapeutics (2021) Vol. 17, Iss. 8, pp. 2595-2601
Open Access | Times Cited: 13
Expanding the role of interventional oncology for advancing precision immunotherapy of solid tumors
Yasushi Kimura, Mario Ghosn, Waseem Cheema, et al.
Molecular Therapy — Oncolytics (2021) Vol. 24, pp. 194-204
Open Access | Times Cited: 12
Ex vivo enrichment of circulating anti-tumor T cells from both cutaneous and ocular melanoma patients: clinical implications for adoptive cell transfer therapy
Tonia Mazzarella, Valeria Cambiaghi, N. Rizzo, et al.
Cancer Immunology Immunotherapy (2011) Vol. 61, Iss. 8, pp. 1169-1182
Open Access | Times Cited: 6
Current Therapies and New Pharmacologic Targets for Metastatic Melanoma
Claudriana Locatelli, Fabiola Branco, Tania Beatriz
InTech eBooks (2013)
Open Access | Times Cited: 4
Pulmonary resection for tissue harvest in adoptive tumor‐infiltrating lymphocyte therapy: Safety and feasibility
Erin M. Corsini, K. G. Mitchell, Nicolas Zhou, et al.
Journal of Surgical Oncology (2021) Vol. 124, Iss. 4, pp. 699-703
Closed Access | Times Cited: 4
Efficacy of cascade-primed cell infusion as an adjuvant immunotherapy with concurrent chemotherapy for patients with non–small-cell lung cancer: A retrospective observational study with a 5-year follow-up
Hong Li, Zhen Zhang, Xiaoran Duan, et al.
Cytotherapy (2020) Vol. 22, Iss. 1, pp. 35-43
Closed Access | Times Cited: 3
Trends in Adoptive Tumor Infiltrating Lymphocytes (TILs) Therapy
Andrali SS
(2015), Iss. 2, pp. 1-6
Open Access | Times Cited: 2
Cellular Uptake of Neutrohpil Elastase Links Inflammation to Adaptive Immunity
Elizabeth A. Mittendorf
(2012)
Closed Access | Times Cited: 1
Tumor Infiltrating Lymphocytes (TIL): From Bench to Bedside
Jeffrey P. Ward
Cancer drug discovery and develogment/Cancer drug discovery and development (2022), pp. 223-248
Closed Access | Times Cited: 1
Lymphocytes in Liver Cancer
Xiaojing Xu, William C. Cho, Jinglin Xia
Translational bioinformatics (2015), pp. 123-141
Closed Access
Tumor Infiltrating Lymphocytes and their Role as a Prognostic Indicator for Melanoma
Sanjay S. Reddy, Stefanos Boukovalas, Victor Barnica, et al.
Journal of Surgery (2014) Vol. S2, Iss. 1
Open Access
Exploiting Epigenetic Modifiers to Circumvent Melanoma Dual Resistance to TCR-Engineered Immunotherapy- and BRAFV600E-Kinase Inhibitor
Ali R. Jazirehi
Springer eBooks (2013), pp. 203-220
Closed Access
Using Adoptive Cell Therapy in the Modern Era of Metastatic Melanoma Treatment
Meredith McKean, Rodabe N. Amaria
Clinical skin cancer (2017) Vol. 2, Iss. 1-2, pp. 32-38
Closed Access
Previous Page - Page 2

Scroll to top